Cancer patients in UK to get immunotherapy drugs in single injection: Is this a faster therapy?
Unlike the traditional hour-long IV drip, this under-the-skin injection takes just 15 minutes, sometimes as little as five minutes, for fortnightly or monthly doses. According to Dr Indoo Ammbulkar, HOD, Medical Oncology, HCG Cancer Centre, Mumbai, the particular drug can reduce the frequency of injections, hospital visits and costs.
How can the new injection be a game-changer in immunotherapy?
Nivolumab is one of the important immunotherapy drugs for cancer treatment, particularly for renal cell cancer, melanoma, lung cancer, head and neck cancer, urothelial, colorectal, hepatocellular carcinoma, and esophageal carcinoma. As per the CHECKMATE 67T trial, not only can it be given via a subcutaneous route, its safety profile is similar to when the drug is administered the conventional way.
It has been well-tolerated with some adverse reactions like fatigue, musculoskeletal pain, pruritus, rash, and cough. Largely it is efficacious and saves the patient's time and logistic issues.
How does single-injection immunotherapy work?
Nivolumab blocks the PD-1 protein, which is a checkpoint that can prevent the immune system from attacking cancer cells. By blocking PD-1, nivolumab helps the immune system recognize and attack cancer cells more effectively. This is a faster way of administering the drug and helps in advanced cancers.
How important is immunotherapy in cancer care?
Immunotherapy has changed the scenario of cancer treatment in the last decade. In the last five years, developments have been quicker. It is not only used in advanced stages but in early stages too. For example, immunotherapy has added years to lives of patients in advanced stages of certain cancers like those of the lungs and skin.
We recommend immunotherapy in early stages of lung and triple-negative breast cancers, even before surgery. If the patient shows a good pathological response, it leads to better survival chances. We will see a lot of cancer patients survive.
What about costs?
The cost of immunotherapy drugs continues to be high in India. Everything depends on scale. But fewer hospital visits can make the treatment journey more convenient and potentially more economical over time.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
10 hours ago
- Hindustan Times
3 European women in Dubai arrested for performing cosmetic surgeries inside an apartment
Cosmetic surgeries are becoming increasingly popular these days, but authorities often warn that they should only be performed by licensed professionals in approved medical facilities. Dubai Police raided the apartment and confiscated equipment used for illegal procedures.(Pexels/Representational Image) Recently, Dubai Police arrested three European women accused of performing unlicensed cosmetic procedures inside a residential apartment. According to a Gulf News report, the arrests were made by the Anti-Economic Crime Department in coordination with the Dubai Health Authority, following a tip-off about suspicious activities at the property. Dubai officers raided the apartment and seized medical equipment allegedly used in the illegal procedures. According to police, the women were performing treatments without the required licences, in violation of laws designed to protect public health and safety. The suspects have been referred to the Public Prosecution for legal proceedings, according to the report. Police did not reveal the women's exact nationalities beyond confirming they were from Europe. Authorities have not provided any information regarding the number of clients who may have undergone these procedures, nor have they specified the exact types of cosmetic surgeries that were performed. NHS warns of cosmetic surgery risks: According to the UK's National Health Service (NHS), all cosmetic procedures carry some risk, whether it is a surgical treatment such as breast implants or a non-surgical option like dermal fillers or Botox. They can lead to serious complications if not performed correctly, and may also affect mental health if the results are not as expected. The NHS also advises caution when considering treatments promoted on social media, urging people to thoroughly research any procedures or clinics they come across online before making a decision. An emerging trend in cosmetic surgery shows a push toward highly exaggerated feminine looks, often resembling childlike features, which experts argue is unhealthy and unrealistic.
&w=3840&q=100)
Business Standard
a day ago
- Business Standard
Eli Lilly to raise UK price of weight-loss drug Mounjaro by 170%
Eli Lilly will raise the UK list price of its weight-loss treatment Mounjaro by up to 170%, it said on Thursday, amid a White House push to get drugmakers to raise medicine prices in Europe to allow for price cuts in the United States. The new price, which also applies to Lilly's type 2 diabetes medicine that has the same name, is effective from September. The price for a month's supply of the highest dose of the medicine will increase from £122 to £330, Lilly said. The higher price will affect those who pay for Mounjaro privately, but will not affect those prescribed the medicine through the British public healthcare system, which has a separate deal, a Lilly spokesperson said. The U.S. drugmaker said that when it launched Mounjaro in Britain it agreed to a list price "significantly below" that in its three other European markets to prevent delays in availability through Britain's National Health Service (NHS). "We are now aligning the list price more consistently," Lilly said. The move reflects how the pharmaceutical industry is navigating policy changes in the United States, by far its most lucrative market, where President Donald Trump is pushing for lower domestic prices and encouraging price hikes overseas. Last week Eli Lilly CEO David Ricks told an investor call that parity between U.S. and European drug pricing was desirable in the long run, though he warned that European governments "are not signing up to pay more for drugs". The U.S. pays more for prescription drugs than any other country, often nearly three times as much as other developed nations. Trump says he wants to narrow this gap to stop Americans from being "ripped off." Reuters reported last week that the Trump administration has been talking to drugmakers about ways to level the playing field for medicine prices. A list price is set by the drug manufacturer before any rebates or discounts. Lilly said it was working with private UK healthcare providers, such as online pharmacies, who can set their own prices, to ensure continued access to the medicines. Lilly launched Mounjaro in the UK in February last year, while rival Novo Nordisk's Wegovy treatment has been available in the country since September 2023.
Hindustan Times
a day ago
- Hindustan Times
Vaccinations to prevent cervical cancer have plummeted in Britain
HUMAN PAPILLOMAVIRUS (HPV) is an unwelcome consequence of a joyful pursuit. Skin-to-skin contact during sex allows the virus to spread, which can lead to genital warts and cancers of the reproductive system. In Britain HPV causes about 3,500 cases of cervical cancer each year and 900 deaths. A vaccination programme that inoculates against the virus—once a runaway success—is floundering. The HPV vaccine is given to children aged between 12 and 15 before they are typically sexually active. Take-up in girls was around 90% in the years up to 2017. Today the rate foryear-ninegirls is 74%, on a par with Sierra Leone. In boys, who have been offered the jab for five years, it has fallen by nine percentage points to 69%. In some areas, such as Luton and Leicester, less than half of children are vaccinated. Chart Vaccination rates have fallen in all of Britain's child-immunisation programmes, but the drop is sharpest for HPV. The evidence of the vaccine's efficacy is unequivocal: a study from Scotland in 2024 found no cases of cancer-causing HPV virus among women who received it a decade earlier. The National Health Service (NHS) wants to eliminate cervical cancer by 2040, but says it needs to achieve a 90% vaccination rate by 2030. To do so means tackling the three Cs of vaccine hesitancy: confidence, convenience and complacency. Confidence in vaccines was dented during the coronavirus pandemic. Surveys conducted by the Vaccine Confidence Project (VCP), a research outfit, find that the share of respondents who agreed that vaccines are 'safe' and 'important for children' declined sharply during the pandemic in many countries, but the drop was especially pronounced in Britain. New survey data from the VCP on vaccine attitudes in Britain, shared exclusively with The Economist, show that confidence in vaccines in general has since improved. Among a representative sample of adults, 85% agree that 'in general, vaccines are safe', 15 percentage points up on 2023. But when asked specifically about the safety of the HPV vaccine, that figure drops to 74%. Blame disinformation. Anti-vax parents allege that it causes ovarian failure and other issues. In 2019 Robert F. Kennedy junior, now America's health secretary, called it 'the most dangerous vaccine ever invented'. Numerous studies have found that its adverse effects are similar to, and no more frequent than, other common vaccines. The UK Health Security Agency (UKHSA) says that the rates of ovarian failure and other illnesses are no greater than would occur naturally in adolescent girls. Are today's schoolchildren affected by anti-vax views? Surveys of teenagers show that they know where to seek information they trust about vaccines: from their parents. Worryingly, the latest VCP survey shows that middle-aged people (ie, the parents of teenagers) are the least likely to say the HPV vaccine is safe. The HPV vaccine is administered in schools, but parents must sign a form to consent to their child being inoculated. The UKHSA says that many go unsigned, not because a parent actively objects but because of a lack of convenience. It wants to tackle this by allowing children to self-consent if the nurse giving the vaccine believes that they are mature enough—though only one in five teenagers say they alone should decide whether to get vaccinated, rising to one in three by age 16. Some parents worry that vaccination might affect their child's behaviour. Dr Tehseen Khan, a GP in the London borough of Hackney, says Orthodox Jews he works with believe the vaccine is unnecessary because their children will have only one life-long partner. Although there is no evidence that having the vaccine changes sexual behaviour, some parents fear that it promotes promiscuity. In Scotland, which (unlike England) publishes data by ethnicity, Pakistani and Polish children have the lowest HPV vaccination rates; white British and Chinese the highest. Complacency may also lead children and parents to wonder why the vaccine is necessary. Helen Bedford of University College London says parents often ask: 'Why do I need to get my child who is not yet sexually active vaccinated against something which may or may not happen to them in 20 or 30 years time?' Vaccination programmes are often victims of their own success, making cervical cancer less common and parents less worried about it. The NHS recently launched a catch-up campaign, targeting some 400,000 women aged under 25 who did not get inoculated in school. Whether they will get a jab may not be down to the facts. Margaret Stanley at the University of Cambridge, whose research helped develop the HPV vaccine, says at this stage you should 'forget the science, it's all about the marketing.' For more expert analysis of the biggest stories inBritain,sign upto Blighty, our weekly subscriber-only newsletter.
